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Abstract
The early inflammatory response to influenza virus infection contributes to severe lung disease and continues to pose a
serious threat to human health. The mechanisms by which neutrophils gain entry to the respiratory tract and their role
during pathogenesis remain unclear. Here, we report that neutrophils significantly contributed to morbidity in a
pathological mouse model of influenza virus infection. Using extensive immunohistochemistry, bone marrow transfers, and
depletion studies, we identified neutrophils as the predominant pulmonary cellular source of the gelatinase matrix
metalloprotease (MMP) 9, which is capable of digesting the extracellular matrix. Furthermore, infection of MMP9-deficient
mice showed that MMP9 was functionally required for neutrophil migration and control of viral replication in the respiratory
tract. Although MMP9 release was toll-like receptor (TLR) signaling-dependent, MyD88-mediated signals in non-
hematopoietic cells, rather than neutrophil TLRs themselves, were important for neutrophil migration. These results were
extended using multiplex analyses of inflammatory mediators to show that neutrophil chemotactic factor, CCL3, and TNFa
were reduced in the Myd88
2/2 airways. Furthermore, TNFa induced MMP9 secretion by neutrophils and blocking TNFa in
vivo reduced neutrophil recruitment after infection. Innate recognition of influenza virus therefore provides the mechanisms
to induce recruitment of neutrophils through chemokines and to enable their motility within the tissue via MMP9-mediated
cleavage of the basement membrane. Our results demonstrate a previously unknown contribution of MMP9 to influenza
virus pathogenesis by mediating excessive neutrophil migration into the respiratory tract in response to viral replication
that could be exploited for therapeutic purposes.
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Introduction
Influenza viruses are highly contagious and cause an average of
226,000 hospitalizations and 36,000 deaths in yearly epidemics
[1]. The emergence of immunologically distinct influenza viruses
to which a whole population is susceptible has resulted in sporadic,
devastating pandemics, such as the recent outbreak of ‘swine flu’
that infected an estimated 61 million people and killed 12,470 [2].
Furthermore, there is growing concern that avian influenza
viruses, which have a significant mortality rate, could mutate to
allow easy human-to-human transmission [3]. Severe complica-
tions arising from pandemic influenza or highly pathogenic avian
viruses are often associated with rapid, massive inflammatory cell
infiltration [4]. Inflammatory cytokines and chemokines have been
associated as their dysregulation correlates strongly with high viral
load and pathology [5]. Following infection, influenza virus
replication occurs in the epithelial cells of the respiratory tract
where innate immune responses are initiated by recognition of the
virus through the inflammasome, which consists of toll-like
receptors (TLRs), retinoic acid-inducible gene-I-like receptors,
and NOD-like receptors [6]. For example, viral double-stranded
RNA and single-stranded RNA are recognized by TLR3 and
TLR7, respectively [7,8]. TLR3/7 signaling induces an inflam-
matory response that promotes a cascade of immune processes
that regulate cellular recruitment and function, including the
induction of cytokines and chemokines. Whereas this process
results in full maturation of dendritic cells (DCs), activation and
recruitment of antigen-specific T cells, and adequate anti-
influenza humoral responses [9,10], aberrant signaling has been
suggested to play a key role in mediating lung pathology that is
characterized by excess inflammation and pulmonary destruction
[4].
MMPs are a family of proteolytic enzymes that are involved in
remodeling the extracellular matrix (ECM) under both physiolog-
ical and pathological conditions [11]. They can be produced by a
range of cells in the respiratory tract, where they mediate wound
healing, airway remodeling, and cell trafficking [12]. As such,
MMPs play an important role in immunity, and their proteolytic
activity can also directly dampen the inflammatory potential by
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excessive responses may contribute to pathology and MMP
activity has been implicated in a variety of pulmonary diseases.
Since MMPs have the potential to cause significant host damage,
their production and function are tightly regulated. For example,
MMPs are rarely stored inside cells and require gene transcription
before secretion, the exceptions being neutrophil MMP-8 and -9,
which are constitutively expressed in granules. Active MMPs can
degrade all components of the ECM and are divided into
subclasses based on their substrate specificity. Collectively known
as the gelatinases, MMP2 and MMP9 cleave denatured collagens
(gelatins) and type IV collagen present in basement membranes
[13]. Although implicated in a range of pulmonary diseases, a
detailed understanding of the involvement of gelatinases in disease
pathology after viral infection is lacking. MMP9 is not expressed in
healthy lungs, but may be released under inflammatory conditions
(such as infections and neoplastic diseases) by macrophages, mast
cells, lymphocytes, and neutrophils. Although neutrophils are the
predominant leukocyte population to be recruited to the lung and
appear early in the immune response to pandemic influenza
viruses [14], the mechanisms by which they gain entry to the
respiratory tract and their role during pathogenesis remain
unclear.
In this study, we sought to identify the role of MMP9 in the
recruitment of neutrophils into the respiratory tract after influenza
virus infection. By increasing the infective dose, we were able to
mimic many of the hallmarks of more virulent ‘‘pandemic’’
infections by virtue of inducing increased morbidity, inflammation,
and lung pathology. High dose infection led to increased
neutrophil recruitment to the lungs and airways, which contrib-
uted significantly to morbidity. We identified neutrophils as the
predominant source of pulmonary MMP9. Importantly, MMP9
was functionally required for neutrophil migration into the lung in
response to infection and for control of viral replication. Although
MMP9 release from neutrophils was TLR-dependent, MyD88-
mediated signals in non-hematopoietic cells, rather than intrinsic
induction, were important for neutrophil recruitment by inducing
the neutrophil chemoattractant CCL3. In addition, MyD88
signaling-induced tumor necrosis factor (TNF)a contributed to
MMP9 release from neutrophils. Our data demonstrate a
previously unknown role of MMP9 to influenza virus pathogenesis
by contributing to excessive neutrophil migration into the
respiratory tract in response to TLR-induced chemotactic factors.
Results
Morbidity, inflammation, and neutrophil number are
increased after infection with high dose influenza virus
Infection of humans with virulent viruses is associated with high
viral titers and increased inflammation [5]. To determine the effect
of infective dose on cytokine/chemokine levels and cellular
recruitment, mice were infected with different doses of Influenza
virus A PR/8/34 (PR8): 125, 1250, or 12500 50% egg infectious
doses (EID50). Morbidity, measured by weight loss, correlated with
the infective dose (Figure 1A). Mice began losing weight as early as
3 days after infection with 12500 EID50 and progressively lost
more until they had to be sacrificed in accordance with animal
welfare guidelines. Although delayed, mice receiving the interme-
diate dose (1250 EID50) lost weight, but recovered with the
appearance of adaptive immunity. Depending on the infective
dose, mice had increased cytokine/chemokine levels in the airways
6 days after infection as measured by multiplex analysis of the
broncheo-alveolar lavage (BAL) (Figure 1B). Inflammatory
cytokines, such as IFNc, interleukin (IL)-6 and TNFa, and the
chemokines, CCL2 and CCL5, were highly upregulated in the
respiratory tract after infection with 12500 EID50. The increased
secretion of inflammatory mediators was associated with increased
cellular infiltrates in the lung 6 days after infection (Figure 1C).
Whereas uninfected lungs had clear airspaces, cellular infiltrates
and bronchoconstriction were observed after infection with 125
EID50. Increasing the dose tenfold resulted in complete obliter-
ation of the normal lung architecture in many foci of infiltration
(Figure 1C, far right). The increased cellularity of the lung was in
part made up by a substantial number of infiltrating neutrophils
(Figure 1D). Analysis of lung and BAL by flow cytometry
demonstrated a significant increase in the number of Ly6G+ cells
in both sites after infection with 12500 EID50. Other cell
populations that increased after infection included macrophages,
CD4 and CD8 T cells (data not shown). To address further
neutrophil recruitment, we utilized LysM-GFP mice, which
express enhanced green fluorescent protein (GFP) from the
lysozyme M gene locus, as a reporter for neutrophil numbers in
the blood [15]. An increased percentage of circulating neutrophils
(GFP
hi side-scatter
hi) could be detected as early as two days after
infection, but only with the higher dose of virus (Figure 1E). Their
percentage kept increasing until mice had to be sacrificed 6 days
after infection. In contrast, neutrophil numbers in LysM-GFP
mice infected with 125 EID50 did not increase and were similar to
uninfected control mice or those given allantoic fluid. Thus, by
using a high dose of infectious virus, we established a model to
induce severe inflammation and increased neutrophil accumula-
tion in the respiratory tract.
MMP9 is produced by neutrophils after infection
Our model allowed us to investigate the contribution of MMPs
to pathogenesis. Gelatinases MMP2 and MMP9 are capable of
cleaving type IV collagen present in the basement membrane and
have been implicated in a variety of pulmonary diseases [13]. We
assessed total gelatinase activity in lung tissue by in situ
zymography 6 days after influenza virus infection (Figure 2A).
Enzymatic cleavage of the probe was significantly increased in the
Author Summary
Influenza-associated morbidity and mortality due to yearly
epidemics and sporadic, devastating pandemics are a
significant health and economic burden. Severe complica-
tions arising from highly virulent viruses are associated
with rapid, massive inflammatory cell infiltration. Although
neutrophils are the predominant cell population recruited
to the lung in response to pandemic influenza viruses, the
mechanisms by which they gain entry to the respiratory
tract remain unclear. In this study, we show a previously
unknown contribution of MMP9 to influenza pathogenesis
by mediating excessive neutrophil migration into the lung,
which not only controls viral replication, but also
contributes to morbidity. The in vivo relevance of MMP9-
derived enzymatic activity in neutrophils is controversial
and understudied, but our data provide new evidence that
innate recognition of influenza virus attracts neutrophils
that secrete MMP9, which enables them to traverse the
basement membrane of the lung by digesting the
extracellular matrix. The dichotomy of MMP9 function in
immunity versus pathology provides real challenges for
targeting MMP9 for therapeutic purposes. Nevertheless,
finding the balance to modulate neutrophil numbers
following influenza virus infection will allow for innate
immunity to be boosted whilst preventing pathology
associated with pandemic strains.
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PLoS Pathogens | www.plospathogens.org 2 April 2012 | Volume 8 | Issue 4 | e1002641Figure 1. Morbidity, inflammation, and neutrophil number are increased after infection with high dose influenza virus. (A) Kinetics of
weight loss as a percentage of starting weight in C57BL/6 mice infected i.n. with 125 (light-grey squares), 1250 (dark-grey triangles), or 12500 (black
circles) EID50 PR8 virus. Mean 6 SEM (n=5, representative of four independent experiments). (B) Cytokine and chemokine levels in the BAL of
uninfected mice (‘control’, clear bars) or mice infected 6 days earlier with 125 (light-grey bars), 1250 (grey bars), or 12500 (dark-grey bars) EID50 PR8
virus. Mean 6 SEM (n=3–4, representative of two independent experiments). (C) Histological examination of uninfected lungs (control, left) or lungs
6 days after infection with 125 (middle) or 12500 (right) EID50 PR8 virus. Perfused lungs were fixed in formalin and stained for hematoxylin and eosin
(scalebar=100 mm). Images are representative of multiple mice. b. bronchiole, a. arteriole, av. alveole, and arrowhead. venule. (D) Neutrophil
numbers in the BAL and lung of uninfected mice (‘control’, clear bars) or mice infected 6 days earlier with 125 (light-grey bars) or 12500 (dark-grey
bars) EID50 PR8 virus. Mean 6 SEM (n=3, representative of two independent experiments). (E) The percentage of blood neutrophils from LysM-GFP
mice infected with 125 (light-grey squares) or 12500 (black circles) EID50 PR8 virus compared to control (PBS, open squares) or allantoic fluid at the
same dilution as the highest viral dose (open triangles). Mean 6 SEM (n=4–5).
doi:10.1371/journal.ppat.1002641.g001
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defined areas, rather than displaying generalized activity through-
out the lung. MMP9 expression correlated with the original
infective dose (data not shown) and appeared to be expressed in
the vicinity of infected cells, which was visualized using double-
staining for MMP9 and viral hemaglutinin (HA) (Figure S1). Of
note was the expression of MMP9 in between the airways and foci
of viral replication (Figure S1B).
MMP9 can be produced in many cell types and to identify a
potential candidate cell population, we transferred C57BL/6 or
Mmp9
2/2 bone marrow into wild-type recipients and allowed the
mice to reconstitute for at least four weeks (tested by flow
cytometry, data not shown). Mice were infected with 12500 EID50
virus and MMP9 secretion was assessed in the airways (BAL) and
lung parenchyma by ELISPOT 6 days later (Figure 2B). Mice
reconstituted with C57BL/6 bone marrow had significantly more
MMP9-secreting cells in both the airways and lung. However,
virtually no MMP9 secretion could be observed when the
hematopoietic system was deficient in mmp9, suggesting that bone
marrow-derived cells produced the majority of MMP9 in the lung
after infection.
To identify the cells that produce MMP9, we did extensive dual
immunofluorescence analysis of lung tissues and found Ly6G+
colocalization with MMP9 (Figure 2C). Unlike the Gr-1 marker,
Ly6G is specifically expressed on neutrophils, but not on
plasmacytoid DC, CCR2+ inflammatory monocytes, or myeloid
suppressor monocytes [16]. Thus, we identified neutrophils as the
predominant cellular source of MMP9 produced after influenza
virus infection.
Depletion of neutrophils during influenza virus infection
abrogates MMP9 secretion
Since neutrophil numbers were significantly increased following
high dose infection and this population appeared to be the
predominant source of MMP9 in the lung after infection, we
sought to identify the direct function of MMP9 in this cell
population. Ly6G is exclusively expressed on neutrophils and
antibody treatment has been shown before to specifically deplete
neutrophils only [17]. Treating C57BL/6 mice one day before
infection and every two days thereafter with an antibody to Ly6G
completely depleted Ly6G+ neutrophils as compared to the
isotype control IgG (Figure 3A). Importantly, in the absence of
neutrophils, there was a significant reduction in weight loss at 5
and 6 days after pathogenic influenza virus infection (Figure 3B).
Our data suggest that neutrophils were pathogenic after high dose
infection and contribute to morbidity. Furthermore, we demon-
strated that MMP9 secretion correlated with morbidity, since
neutrophil depletion also significantly reduced MMP9 exocytosis
(Figure 3C), confirming our results that MMP9 was predominantly
produced by neutrophils after influenza virus infection (Figure 2C).
In addition to containing MMP9 in preloaded granules,
neutrophils are capable of secreting a variety of inflammatory
Figure 2. MMP9 is produced by neutrophils after infection. (A) MMP2/9 activity in lungs of uninfected control mice (left panel) or those 6 days
after infection (right panel). Gelatinase activity was measured by in situ zymogram and visualized by green fluorescence after enzymatic cleavage to
release fluorochrome from a quencher (scalebar=50 mm). Images are representative of multiple mice. (B) MMP9 secretion by cells from BAL and lung
from Ly5.1 recipient mice that received BM from either Mmp9
2/2 (clear bars) or C57BL/6 (grey bars) donors was measured by ELISPOT. Mean 6 SEM
(n=5–7, representative of two independent experiments). (C) Ly6G+ lung neutrophils (red) and MMP9+ cells (green), and their colocalization (merge,
right panel) were visualized by immunofluorescence of infected lung 6 days after infection (scalebar=50 mm). Images are representative of multiple
mice.
doi:10.1371/journal.ppat.1002641.g002
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MMP9 response after infection indirectly. Therefore, the levels of
innate mediators in the BAL were tested 6 days after infection by
bead array analysis. The concentrations of the tested inflammatory
cytokines and chemokines were similar between the anti-Ly6G
and isotype-treated mice (Figure 3D), excluding a direct effect of
these neutrophil-derived soluble mediators in influenza virus
pathogenesis. Although a recent study demonstrated that neutro-
phils enhanced the response of virus-specific CD8 T cells [19], we
did not observe differences in IFNc production by CD8 T cells
between the antibody-treated groups in our model (Figure S2).
Thus, our data demonstrate that Ly6G+ neutrophils are capable of
producing MMP9 and do not affect influenza virus pathogenesis
through production of inflammatory mediators or by indirectly
affecting CD8 T cell function.
Neutrophils require MMP9 to migrate to the respiratory
tract
Unlike the chemokines, our results implicate MMP9 in
neutrophil-mediated morbidity. Although controversial, proteolyt-
ic digestion of the basement membrane lining the lung
endothelium has been proposed to be able to mediate migration
of cells [20]. To address the functional role of MMP9 during
influenza virus pathogenesis, we infected C57BL/6 and Mmp9
2/2
mice and quantified the number of neutrophils in the respiratory
tract. Ly6G+ cells were significantly decreased in both BAL and
Figure 3. Depletion of neutrophils abrogates MMP9 secretion after influenza virus infection. Neutrophils were depleted by injecting
C57BL/6 mice with 400 mg anti-Ly6G antibody (aLy6G) or isotype control (IgG) one day before infection and every other day thereafter. (A) Depletion
of Ly6G+ cells in aLy6G-treated C57BL/6 mice (bottom panel) compared to IgG (top panel) was verified by flow cytometric analysis 6 days after
infection. (B) Kinetics of weight loss as a percentage of starting weight in uninfected (control, open symbols) and infected (closed symbols) mice
treated with the aLy6G (squares) or IgG isotype (circles). (C) MMP9 secretion by cells from BAL and lung from infected mice that were treated with
aLy6G (clear bars) or IgG isotype (grey bars) was measured by ELISPOT. (D) Inflammatory cytokine release in airways after neutrophil depletion. BALs
were collected 6 days after infection and supernatants assayed by bead array. (B–D) Mean 6 SEM (n=3, representative of two independent
experiments). (B–C) Considered significant at *P,0.05, ***P,0.001.
doi:10.1371/journal.ppat.1002641.g003
MMP9 Contributes to Influenza Virus Pathogenesis
PLoS Pathogens | www.plospathogens.org 5 April 2012 | Volume 8 | Issue 4 | e1002641lung from the Mmp9
2/2 mice 6 days after infection (Figure 4A). As
a consequence, the viral load in the lungs of the Mmp9
2/2 mice
was significantly increased, demonstrating that MMP9, and
possibly neutrophils, are required for viral clearance (Figure 4B).
Airway levels of CXCL1, CCL2, CCL3, CCL5, IFNc, IL-6, and
TNFa were measured 3 and 6 days after infection. We could only
identify significant increases in CXCL1 both days (Figure 4C and
Figure S4). Recovery of alveolar macrophages (F4/80
hiCD11c
hi)
and exudate macrophages (F4/80
intCD11c
int), which could
contribute to the inflammatory response, were not significantly
different 3 days after infection of Mmp9
2/2 mice compared to
C57BL/6 controls (Figure S3A). Likewise, lung pathology was not
impacted in Mmp9
2/2 mice at this time point (data not shown).
These results support the notion that MMP9 is crucial for
neutrophil, but not macrophage, migration to the infected lung
and thereby not only contributes to influenza virus pathogenesis,
but is also required for control of viral replication.
Neutrophil recruitment, MMP9 secretion, and viral load
are TLR-dependent
We next investigated the mechanism(s) responsible for MMP9-
mediated neutrophil migration. Since influenza-associated inflam-
mation is initiated and dependent on TLRs [7,8], we inquired if
TLR signaling was also involved in MMP9-mediated neutrophil
recruitment. To this end, mice deficient in the TLR adaptor
molecule MyD88 (mediates all TLR signaling, except for that by
TLR3) and Tlr3
2/2 mice were infected with 12500 EID50 and the
effect on viral replication, MMP9 secretion, and neutrophil
numbers was assessed. Morbidity in both strains was not
significantly different (data not shown). Furthermore, overall lung
pathology was only marginally ameliorated in Myd88
2/2 mice 3
days after infection (data not shown). However, viral titers were
significantly increased in the lungs of Myd88
2/2 mice (p,0.01),
but not Tlr3
2/2 mice 3 days after infection (Figure 5A). When
cellularity was examined by flow cytometry, the percentage of
neutrophils in the lungs was significantly reduced in Myd88
2/2
(p,0.001) and Tlr3
2/2 (p,0.05) mice (Figure 5B–C). In
accordance, MMP9 secretion was also significantly reduced in
the airways in both strains (Figure 5D–E). In contrast, recovery of
exudate macrophages from the airways of Myd88
2/2 or Tlr3
2/2
mice compared to C57BL/6 controls was similar 3 days after
infection (Figure S3B–C). However, whereas alveolar macrophage
recovery was unaffected in Myd88
2/2 mice, there was a significant
decrease in their percentage in the Tlr3
2/2 mice. These results
highlight a role for MyD88-derived signals in MMP9 production
from neutrophils.
TLRs are expressed on neutrophils [18,21] and following
ligation could induce activation. An inability to recognize the virus
may therefore result in decreased MMP9 granule exocytosis.
However, it was unclear from our approach whether MMP9
secretion is impaired due to the absence of TLRs in/on the
neutrophils themselves or if the absence of MyD88 signaling in
other cells affected neutrophil migration, thereby indirectly
reducing MMP9 levels in the Myd88
2/2 airways. In order to
distinguish the contribution of MyD88 signaling by immune cells
versus non-hematopoietic cells, two bone marrow transfer
approaches were used. In the first, bone marrow cells from
C57BL/6 or Myd88
2/2 mice were transferred into Ly5.1
recipients (WT.WT and knock-out (KO).WT, respectively).
Upon reconstitution, all groups were infected with 12500 EID50
and 3 days later the number of neutrophils was enumerated by
flow cytometry. No differences could be observed in the lungs
(Figure 5F) or BALs (data not shown) of mice receiving wildtype or
Myd88
2/2 bone marrow, suggesting that MyD88 signaling in
neutrophils themselves is not involved. In the second set of
experiments, the inverse approach was performed by transferring
Figure 4. Neutrophils require MMP9 to migrate to the respiratory tract. (A) Neutrophil numbers in the BAL (left panel) and lung (right panel)
were enumerated by flow cytometry 3 days after infection of C57BL/6 mice or Mmp9
2/2 mice. Control mice were not infected. Mean recovery
numbers per lung 6 SEM (n=3–4, representative of three independent experiments). (B) Viral load was enumerated in left lung lobe by quantitative
RT-PCR for the influenza PA gene 3 days after infection. Mean PA copies/lung 6 SEM (n=4). (C) Chemokine levels in airways of Mmp9
2/2 mice after
infection. BALs were collected 3 and 6 days after infection and supernatants assayed for CXCL1 by bead array. Mean 6 SEM (n=4, representative of
two independent experiments). (A–C) Considered significant at *P,0.05, **P,0.01.
doi:10.1371/journal.ppat.1002641.g004
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Myd88
2/2 recipients (WT.WT and WT.KO, respectively). In
these experiments, a reduction in the number of neutrophils
gaining access to the respiratory tract of the Myd88
2/2 recipients
was observed (Figure 5F). Interestingly, the data suggest that
MyD88 signaling in non-hematopoietic cells is responsible for
neutrophil migration into the lung, rather than TLR recognition
affecting neutrophil MMP9 secretion directly.
Neutrophil chemotactic factors in the airways are MyD88-
dependent
The indirect nature of MyD88-mediated neutrophil recruitment
suggests that chemotaxis to the respiratory tract could be affected.
To assess whether reduced cytokine or chemokine expression
contributed to the decreased neutrophil accumulation, levels of
soluble mediators in the BALs of Myd88
2/2 mice were analyzed
3 dpi (Figure 6). CCL2, CCL5, IFNc, IL-1b, IL-6, and IL-17 were
not different between wildtype and genetically deficient mice (data
not shown). However, in keeping with the reduced neutrophil
levels, CCL3 and TNFa levels were reduced in the airways of
Myd88
2/2 mice. The role of chemoattractant CCL3 has been
described in neutrophil recruitment and suggested that influenza
virus recognition via TLRs in the lung induces chemotactic factors
that facilitate neutrophil migration into the infected lung.
We further wanted to investigate the role of TNFa in MMP9-
mediated neutrophil recruitment. In vivo anti-TNFa antibody
administration of C57BL/6 mice one day before infection and
every day thereafter resulted in a significant reduction in
neutrophil recruitment 3 days after administration of 12500
EID50 PR8 (Figure 6C). Furthermore, MMP9 secretion tended to
be lower in the lung following anti-TNFa antibody treatment
(p=0.07) (Figure 6D). Since the effect of TNFa on neutrophil
recruitment in vivo may be multifactorial (e.g. differential adhesion
receptor expression on the endothelium), the direct consequence of
TNFa on enriched neutrophils was tested in vitro. Negatively
enriched neutrophils were stimulated with different doses of
recombinant TNFa and MMP9 secretion tested by ELISPOT
(Figure 6E). A dose-dependent increase in MMP9 secretion was
observed, highlighting the direct role of TNFa in regulating
MMP9 release from neutrophils. Altogether these data demon-
strate a mechanistic link between influenza virus-induced MyD88
signaling in non-hematopoietic pulmonary cells to facilitate
neutrophil recruitment by inducing chemotactic and proteolytic
mediators needed for their motility in situ.
Discussion
Although implicated in a variety of pulmonary diseases, most
notably asthma and tuberculosis, a detailed understanding of the
Figure 5. Neutrophil recruitment, MMP9 secretion, and viral load are TLR-dependent. Neutrophil numbers and MMP9 secretion are
decreased in TLR-deficient mice. (A–E) C57BL/6 (grey bars), Myd88
2/2, and Tlr3
2/2 (both clear bars) mice were infected with 12500 EID50 PR8. (A) The
viral load was enumerated in left lung lobes of C57BL/6, Myd88
2/2, and Tlr3
2/2 mice by quantitative RT-PCR for the influenza PA gene 3 days after
infection. Mean PA copies/lung 6 SEM (n=4, representative of two independent experiments). (B, C) The percentage of neutrophils in lungs of
Myd88
2/2 and Tlr3
2/2 mice, respectively, were enumerated by flow cytometry 6 days after infection. (D, E) The number of cells secreting MMP9 in the
airways of mice deficient in TLR signaling. MMP9 ELISPOT analysis of BALs from (D) Myd88
2/2 or (E) Tlr3
2/2 mice. Mean 6 SEM (n=4–5,
representative of two independent experiments). (F) Neutrophil recoveries in lung 3 days after infection of mice receiving bone marrow transfer. The
percentage of neutrophils after transfer of C57BL/6 (WT.WT) or Myd88
2/2 (KO.WT) bone marrow into Ly5.1 congenic mice (grey bars) or after
transfer of Ly5.1 bone marrow cells into Ly5.2+ C57BL/6 (WT.WT) or Myd88
2/2 (WT.KO) recipients (clear bars) is shown. (A–E) Mean 6 SEM (n=3,
representative of two independent experiments). (A–F) Considered significant at *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.ppat.1002641.g005
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this study, we addressed the contribution of MMP9 during
influenza virus pathogenesis, which had been implicated recently
by virtue of increased concentrations in the serum of patients with
influenza and elevated enzymatic activity in mouse lung
homogenates [22,23]. However, the cellular origin and direct role
of MMPs in the pathogenesis of influenza virus have not been
previously examined. Thus, we focused on elucidating the effects
of MMP9 in a pathological mouse model and identified
neutrophils as the predominant pulmonary source of MMP9.
We demonstrated that MMP9 mediated neutrophil migration into
the infected respiratory tract and that it was required for viral
clearance. Although MMP9 release was TLR signaling-depen-
dent, MyD88-mediated signals in non-hematopoietic cells, rather
than neutrophil TLRs themselves, were important for neutrophil
recruitment. This is most likely due to MyD88-controlled
induction of the known neutrophil chemoattractant, CCL3, as
well as TNFa, which we found induced MMP9 secretion in
neutrophils. Our data demonstrate a previously unknown role of
MMP9 to influenza virus pathogenesis by contribution to excessive
neutrophil migration into the respiratory tract.
Using a model wherein a lethal dose of virus mimics many of
the characteristics observed after pandemic infections, with greater
cytokine/chemokine levels, lung pathology, and inflammatory
cells [5,14], we showed that MMP9 activity was upregulated in
infected lungs, confirming data published recently [23,24]. We
extended these studies by demonstrating that MMP9 was
exclusively produced by hematopoietic cells. It is surprising that
non-hematopoietic cells did not contribute to MMP9 secretion, as
it can be induced under inflammatory conditions in lung epithelial
and endothelial cells [25]. Nevertheless, our data further indicated
that MMP9 was predominantly secreted in the lung by
neutrophils. Neutrophil depletion caused a significant reduction
in the number of cells being able to produce MMP9, but did not
abrogate all MMP9 production, suggesting that other immune
cells can also contribute. In a recent study, neutrophil depletion
did not affect MMP9 levels in the BAL 5 days after sublethal
influenza virus infection, which is at odds with our results [24].
However, contributing factors to this discrepancy most likely
involve the timing, which was later, and the infective dose, which
was lower. Nevertheless, excessive neutrophil infiltration into the
lung correlated with increased MMP9 production and viral
replication when macrophages were depleted [24], which supports
our findings. However, the source of MMP9 was not identified.
We are currently investigating the potential role of other cell
populations that are capable of producing MMP9 under
inflammatory conditions, such as lymphocytes [13]. However,
unlike these cells, neutrophils do not require de novo generation of
MMP9 and instead are preloaded in the bone marrow and
exocytose their granules following stimulation. In addition, they
can synthesize and secrete cytokines and chemokines [18],
although we were unable to demonstrate a significant contribution
Figure 6. MyD88-dependent TNFa expression induces MMP9 in neutrophils. (A–B) BALs of C57BL/6 (grey bars) and Myd88
2/2 (clear bars)
mice infected 3 or 6 days earlier were analyzed by bead array. Airway levels of (A) CCL3 and (B) TNFa. Mean 6 SEM (n=3, representative of two
independent experiments). (C–D) TNFa function was blocked by injecting C57BL/6 mice with 200 mg anti-TNFa (aTNFa, clear bars) or IgG isotype (IgG,
grey bars) daily starting one day before infection. (C) The percentage of neutrophils in lungs of antibody-treated mice was enumerated using flow
cytometry 3 days after infection. (D) The number of cells secreting MMP9 in the lungs was assessed by ELISPOT 3 days after infection. Mean 6 SEM
(n=5, representative of two independent experiments). (E) Neutrophils were negatively enriched from the bone marrow of C57BL/6 mice and
stimulated with different doses of recombinant TNFa for 6 hours. MMP9 expression during the 6 hour incubation was assessed by ELISPOT (n=3,
representative of two independent experiments). (A–C) Considered significant at *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.ppat.1002641.g006
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neutrophils did not cause a significant difference in an extensive
panel of potential candidates.
While neutrophils are a major cell population recruited to the
lung early in the immune response to pandemic influenza viruses
[14,26], their role during pathogenesis remains unclear. Depletion
studies demonstrated enhanced susceptibility of mice to infection,
exacerbated inflammation, and increased viral titers and mortality
rates [24,26,27,28], which suggested a critical contribution of
neutrophils to innate immunity. In contrast, other studies parallel
ours and show that neutrophils contribute to disease during severe
influenza virus infection [29,30,31]. The disparate results may be a
consequence of differential infective doses and genetic back-
ground. Nevertheless, we show for the first time that MMP9 may
contribute to pathogenesis by mediating excessive neutrophil
migration into the respiratory tract in response to viral infection.
While depletion of neutrophils reduced morbidity, MMP9 was still
required for viral clearance. It is likely that the same mechanism(s)
that contribute to immunity cause pathology in a more virulent
setting [4]. Neutrophils are able to inhibit virus replication in vitro
and the release of anti-viral molecules by neutrophils could
contribute to viral clearance from the lung [24,27,32]. However,
the mechanisms that allow for neutrophil influx in response to
uncontrolled or high viral load, such as MMP9 proteolytic activity,
may exacerbate pathology due to collateral destruction of the lung
ECM. This could explain the apparent contradicting reports on
the role of neutrophils in viral infections and suggests that, while
they contribute to viral clearance, excessive numbers contribute to
pathology.
We showed that MMP9 functions by regulating neutrophil
localization to the respiratory tract. Cellular influx into the airways
is a complex process whereby cells cross the endothelial cell layer,
the basement membrane, and the epithelial cell layer. Although
rolling and tethering on the endothelium has been described in
detail, the means by which cells further progress through the
basement membrane to reach the airways remain unclear [33].
Whereas gelatinase activity has been implicated in neutrophil
migration through artificial basement membranes in vitro, its
relevance in vivo remains controversial [20]. Chemokine-induced
migration of neutrophils in an induced lung inflammation model
was demonstrated to be independent of MMP9 [34], whereas that
in a dermal model did require MMP9 [35]. In part, this
discrepancy may be due to the artificial nature of the experiments:
while chemokines may be able to mimic inflammation and attract
cells, crucial factors necessary for the release of MMP9 may not be
available as they are not induced by the chemokine itself (see
below). The presence of these required accessory molecules is
assured in the influenza model, but at the same time can be
difficult to define. Nevertheless, we were able to identify at least
one, TNFa, which was able to induce MMP9. It is still of great
interest to identify other factors during influenza virus infection as
they have obvious clinical relevance. Thus, our data not only
demonstrate a role for MMP9 in influenza pathogenesis, but also
provide further in vivo evidence for MMP9 activity as a mechanism
by which neutrophils digest the extracellular matrix to traverse the
basement membrane in order to gain access to the infected lung
epithelium. The colocalization of MMP9 and viral antigen and its
expression between the endothelium and areas of viral replication
support this hypothesis. In addition to its role in mediating
proteolytic cleavage of the basement membrane to allow for
motility within the lung, MMP9 may also modulate chemokine
expression itself by digesting CXCL-1 [13]. Our finding that
CXCL-1, a potent neutrophil chemoattractant, is significantly
upregulated in the Mmp9
2/2 mice following infection hints at a
negative feedback loop in which MMP9 release by neutrophils
disrupts the CXCL-1 gradient and dampens further neutrophil
recruitment in the absence of influenza virus.
We hypothesized that TLRs are important to induce MMP9
secretion from neutrophils. These innate pattern recognition
receptors are expressed by neutrophils [18]. Furthermore, viral
RNA has been detected in neutrophils [36], which could facilitate
access to TLRs inside endosomes, such as TLR3 and TLR7,
which have both been shown to be able to recognize influenza
virus. Indeed, TLR7 signaling was demonstrated to be able to
activate neutrophils in response to influenza virus, although this
was dependent on GM-CSF [21]. Therefore, we examined the
role of TLR signaling in neutrophil activation in Tlr3
2/2 and
Myd88
2/2 mice. MyD88 is the adapter molecule for all known
TLRs with the exception of TLR3, and the inclusion of both
strains therefore encompassed all potential TLR-mediated effects.
Although both neutrophil accumulation and MMP9 secretion
were reduced following high dose influenza virus infection, our
bone marrow chimera approach demonstrated that this was not a
direct effect as Myd88
2/2 neutrophils still migrated into the
respiratory tract. Furthermore, in vitro stimulation with influenza
virus of neutrophils enriched from Myd88
2/2 mice did not affect
MMP9 secretion (data not shown). Rather, Myd88
2/2 signaling in
non-hematopoietic cells was important for neutrophil accumula-
tion. When we examined chemokine levels in the airways of
Myd88
2/2 mice, CCL3, a known neutrophil chemoattractant, was
downregulated. Thus, it appears that rather than a direct effect on
MMP9 activation, ablation of MyD88 signaling may have affected
the chemokine gradient that would normally attract the neutro-
phils to the sites of viral replication. In addition, TNFa induced
the release of MMP9 from neutrophils and antibody blocking of
TNFa prevented their recruitment into the lungs in response to
influenza virus infection in vivo. TNFa has been demonstrated
previously to induce MMP9 exocytosis in a protein kinase C-
dependent fashion [37] and we hypothesize that the reduced levels
in the Myd88
2/2 airways prevented MMP9 release and resulted in
reduced neutrophil numbers.
The role of neutrophils in viral infections has often been
overlooked, on the pretext that they are mostly involved in the
clearance of bacterial and fungal pathogens. Their contribution to
influenza virus-induced pathology is unclear, but we showed in our
pathological model that they contributed to morbidity. Further-
more, we demonstrated that the mechanism for neutrophil-
mediated migration to the respiratory tract in response to
influenza required MMP9 and depended on extrinsic TLR-
signaling. Collectively, our results suggest that innate sensing of
viral infection results in a MyD88-dependent induction of
chemotactic factors that induce the recruitment of neutrophils.
Following diapedesis into the lung parenchyma, MyD88-induced
TNFa in non-hematopoietic cells induces MMP9 release in
neutrophils and MMP9 enzymatic activity is utilized by these cells
to degrade the basement membrane and facilitate their motility
within the lung. These novel findings are probably not restricted to
influenza pathogenesis, but may also have implications for other
viral infections. The dichotomy of the necessity for MMP9-
mediated immune cell migration and its role in immunopathology
provides real challenges for targeting MMP9 for therapeutic
purposes after influenza virus infection. Nevertheless, finding the
balance to modulate neutrophils allows for innate immunity to
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All experiments in this study were approved by the Institutional
Animal Care and Use Committee (IACUC) at the Sanford-
Burnham Medical Research Institute and were carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health.
Mice and infection
Male C57BL/6J (C57BL/6J ) mice and B6.SJL-Ptprca Pep3/




2/2 [40], or LysM-GFP [15]
mice (all on C57BL/6 background) were obtained with permission
as gifts from Drs S. Swain (University of Massachusetts, MA), M.
Corr (University of California, San Diego, CA), F. Kherradmand
(Baylor College of Medicine, TX), and G. Srikrishna (Sanford-
Burnham Medical Research Institute, CA), respectively. All mice
were used at 6–16 weeks of age and held under specific-pathogen-
free conditions in the vivarium at the Sanford-Burnham Medical
Research Institute.
Influenza virus A PR/8/34 (PR8, H1N1) was grown in the
allantoic fluid of 10-day-old embryonated eggs (McIntyre Poultry,
San Diego) and stored at 280uC until use. Before infection, mice
were anesthetized by intraperitoneal injection of 100 mL keta-
mine/xylazine (14.3 mg/mL Ketaset (Fort Dodge, IA)/2.86 mg/
mL Anased (Lloyd Laboratories, IA)). Mice were infected with
1.25610
4 EID50 influenza virus (unless otherwise stated) in 50 mL
by the intranasal route. Mice were terminated at the indicated
timepoints or when clinical signs reached pre-defined endpoints
(body weight loss of 30%) by intraperitoneal injection of avertin
(2% (w/v) 2,2,2-tribromoethanol, 2% (v/v) tert-amyl-alcohol) or
CO2 inhalation.
Preparation of BAL and lung cell suspensions
Cells from the airways and lung were obtained from infected
mice at the indicated timepoints. Cells from airways were obtained
via BAL by piercing the diaphragm, transecting the trachea, and
infusing the lungs with 1 mL PBS through an 18-gauge catheter
(Terumo, USA). The resulting cell suspension was centrifuged
(5 min, 3006g), the supernatants aspirated and stored at 280uC
for cytokine bead array (see below), and the cells resuspended in
wash medium (HBSS (CellGro, USA) supplemented with 1% (v/v)
heat-inactivated fetal calf serum, 5 mM HEPES (CellGro), and
100 U/mL Pencillin, 100 mg/mL Streptomycin, 292 mg/mL L-
glutamine (Mediatech)). Perfused lungs were cut into small pieces,
digested in 2 mL collagenase (1 mg/mL collagenase D (Roche,
USA), 0.5% bovine serum albumin (BSA, Sigma), 100 mg/mL
Dnase) for 60 min at 37uC, and filtered and homogenized over a
70 mm cell sieve. Cell suspensions were washed and resuspended
in cell medium and the cell numbers enumerated.
Cytokine bead array
Cytokine production in the airways after infection was
measured using a Legend-plex custom cytokine/chemokine array
according to manufacturer’s instructions (Biolegend, USA).
Supernatants aspirated from BAL were assayed for indicated
combinations of the following analytes: IL-1b, IL-6, IL-12p40, IL-
17a, IFNc, CXCL1, CCL2, CCL3, CCL5, and TNFa. Samples
were analyzed on a Luminex IS200.
Flow cytometry
The percentage of neutrophils present in the airways or lung
after infection was analyzed by flow cytometry. Recovered cells
were stained with monoclonal anti-mouse antibodies Ly6G-APC
(1A8) and Gr1-PE (RB6–8C5) (Biolegend). Cells were stained for
15 min on ice before being washed and analyzed on a
FACSCalibur or LSR2 Fortessa flow cytometer (Becton Dick-
inson, CA) using FlowJo 8.8.6 (Tree Star, Ashland, USA). The
number of neutrophils in each tissue was calculated from the cell
recovery and the percentage positive by flow cytometry.
Histochemistry, immunostaining, and in situ gelatinase
assay
For microscopic analysis of pathology, lung tissues were fixed in
buffered formaldehyde-saline (pH 7.5), embedded in paraffin, and
sectioned. Each lung was stained with H&E prior to examination.
Tissues sections for immunofluorescence staining were cut (8 mm)
using a cryostat (Leica Jung CM3000), air-dried overnight, fixed in
acetone for 10 min, and stored at 235uC. Endogenous biotin in
sections was blocked (Invitrogen, USA) before addition of
antibodies: purified anti-MMP9 (1:250, Millipore), goat anti-
rabbit IgG Alexa Fluor 488 (1:100, Invitrogen), anti-Ly6G-Biotin
(1:500, Biolegend), and streptavidin-AlexaFluor 568 (1:1000,
Invitrogen). All antibodies were diluted in 6% (w/v) BSA in PBS
and sections washed 36in PBS between antibodies. Sections were
incubated at room temperature for 60 min with primary antibody
and 30 min with the conjugated antibody. Sections were mounted
using Vectashield hard set mounting media (Vector Labs) and
immunofluorescent staining analyzed with a fluorescence micro-
scope (BX50, Olympus) using UPlanFl 206 or 406 objectives
(Olympus, both at ‘/0.17). Images were recorded using a
SpotFlex camera and SpotSoftware 4.6 (Diagnostic Instruments).
In situ gelatinase assay was performed on frozen sections as
described before [41]. Briefly, 1% (w/v) low-gelling agarose
(Seaplaque) was heated, supplemented with DAPI (1 mg/mL) and
allowed to cool. The agarose was mixed 9:1 with DQ-Gelatin
(1 mg/mL, Invitrogen) and layered atop fresh lung sections, which
were cut as described above. Gelatinase (MMP2/MMP9) activity
was assessed after an 18 hr incubation as described.
Bone marrow transfer
Recipient mice were irradiated 26 with 450 RAD 8 hr apart
and given tetracycline (125 mg/500 mL) or sulfamethoxazole and
trimethoprim (40 mg/500 mL and 200 mg/500 mL) in the
drinking water. Donor cells were prepared from bone marrow
collected from femurs and tibias of donor Mmp9
2/2, Myd88
2/2,
Ly5.1, or C57BL/6 mice and single cell suspensions prepared by
passing the BM through a 25G needle and lysing the red blood
cells with 0.15 M NH4Cl prior to transferring 4–5610
6 cells i.v. to
irradiated recipients as indicated. Reconstitution of the recipients
by donor BM cells was allowed for at least 4 weeks and was tested
by flow cytometric analysis of the recipient’s blood using the
appropriate congenic markers. Briefly, blood samples (,40 mL)
were drawn by retro-orbital bleed, red blood cells lysed, and cells
stained using Ly5.1 FITC (eBioscience, San Diego, CA) and Ly5.2
PerCP (Biolegend, San Diego, CA). The percentage of reconsti-
tution was calculated after flow cytometry and was always higher
than 95%.
Virus titration
Lungs were removed from mice, snap-frozen in liquid nitrogen,
and stored at 280uC prior to viral titer. Lungs were homogenized
as described before [42] and the presence of influenza virus was
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homogenized lung supernatant into the allantoic fluids of 10-day-
old embryonated eggs (McIntyre Poultry, San Diego), followed by
hemagluttination assay using chicken red blood cells [43].
Alternatively, viral titers were assessed by PA copy number per
lung [44]. Briefly, RNA was prepared from homogenates of the
left lung lobe using Trizol (Invitrogen) and RNeasy (Qiagen), and
the polymerase (PA) gene of PR8 amplified using one-step RT
qPCR (Eurogentech) by ABI 7900HT (Applied Biosystems). Data
were analyzed using SDS 2.3 (Applied Biosystems) and the PA
copy number per lung lobe calculated using a PA-containing
plasmid (a gift from Dr S. Swain (University of Massachusetts,
MA) of known concentration as a standard.
In vivo neutrophil depletion
Neutrophils were depleted by i.p. injection of 400 mg anti-Ly6G
(1A8 clone, Biolegend) per mouse 1 day before infection and every
other day following. Control groups received 400 mg rat isotype
control (RatIg, Jackson Immunoresearch) at the same time points.
MMP9 ELISPOT
Secretion of MMP9 in the respiratory tract was analyzed by
ELISPOT assay. Cell suspensions of BAL and lung were prepared
as described above and 5610
3 or 1610
4 cells, respectively,
resuspended in culture medium (RPMI (CellGro) supplemented
with 10% (v/v) heat-inactivated fetal calf serum, 20 mM HEPES
(CellGro), 50 mM b-mercaptoethanol, 100 U/mL Pencillin,
100 mg/mL Streptomycin, 292 mg/mL L-glutamine (Mediatech)).
The cell suspensions were then added in triplicate to wells of a 96-
well plate (Immobilin-P, Millipore), which had been coated with
MMP9 capture antibody (R&D, USA) overnight at 4uC. Cells
were incubated overnight at 37uC, 5%CO2, washed, and detection
MMP9 antibody added overnight at 4uC. MMP9 spots were
visualized with ELISPOT development module (R&D Systems)
and enumerated on an Immunospot reader (Cellular Technology
Ltd, Seattle).
In vivo TNFa blocking
TNFa was neutralized by i.p. injection of 200 mg anti-TNFa
(XT3.11 clone, BioXcell) per mouse 1 day before infection and
every day following. Control groups received 200 mg RatIg
(Jackson Immunoresearch) at the same time points.
TNFa stimulation of purified neutrophils in vitro
Bone marrow cells were collected from femurs and tibias of
C57BL/6 mice and neutrophils were enriched using magnetic
negative enrichment according to manufacturer’s instructions
(Stemcell Technologies). Neutrophils (purity .80% by flow
cytometry) were then incubated with 0, 1, 10, 100, or 1000 pg/
mL recombinant TNFa (R&D Systems) for 6 hours in wells of a
96-well plate (Immobilin-P, Millipore), which had been coated
with MMP9 capture antibody (R&D Systems). The MMP9
ELISPOT was finished as described above.
Statistical analysis
All data were analyzed with Prism software (Graphpad software,
USA). Unless otherwise noted, a two-tailed Mann-Whitney test
was used to compare two treatment groups. Larger groups were
analyzed with Kruskal-Wallis analysis of variance. Where possible,
results are expressed as means 6 SEM. Values of p,0.05 were
considered statistically significant.
Accession numbers
Murine proteins (Swiss-prot): MMP9: P41245, TLR3:
Q99MB1, MyD88: P22366, TNF: P06804, CCL3: P10855,
CXCL-1: P12850.
Supporting Information
Figure S1 MMP9 expression colocalizes with viral
antigen. Matrix metalloprotease 9 (MMP9) and the viral protein
hemaglutinin (HA) were visualized by immunofluorescence of
lungs 6 days after infection. (A) HA (green, top panel) and MMP9
expression (green, bottom panel) in lungs of control and infected mice.
(B) HA expression (green), MMP9 positive cells (green), and their
colocalization (merge, right panel) were visualized by double staining
of infected lungs. Dotted line denotes the border of the infection
focus (HA+). av. alveole and a. arteriole. Images are representative
of multiple mice (scalebar=50 mm).
(TIF)
Figure S2 Depletion of neutrophils does not affect CTL
function. Neutrophils were depleted by injecting C57BL/6 mice
with 400 mg anti-Ly6G (aLy6G) or IgG control isotype (IgG) one
day before infection and every other day thereafter. Six days after
infection, IFNc secretion by CD8 T cells from BAL and lung of
mice that were treated with IgG (grey bars)o raLy6G (clear bars) was
enumerated by intra-cellular cytokine staining after stimulating
cells with anti-CD3 overnight in the presence of Brefeldin A.
Mean 6 SEM (n=3, representative of two independent
experiments).
(TIF)
Figure S3 Recovery of alveolar and exudate macrophag-
es from airways after infection. The percentage of




2/2 mice (clear bars) was enumerated by flow cytometry 3 days
after infection and compared to C57BL/6 mice (grey bars).
Macrophage populations were divided into alveolar and exudate
macrophages based on their expression of F4/80 and CD11c (see
axes). Mean recovery numbers per BAL 6 SEM (n=3–4).
(TIF)
Figure S4 Cytokine/chemokine profile in airways of
Mmp9
2/2 mice after infection. Inflammatory cytokine
release in C57BL/6 or Mmp9
2/2 mice after infection. BALs were
collected 3 and 6 days after infection and supernatants assayed by
bead array for indicated inflammatory mediators. Mean 6 SEM
(n=4, representative of two independent experiments).
(TIF)
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